Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 81 | 5,278 | 0 | 0 | 0 |
| Gross Profit | 81 | 5,278 | N/A | N/A | N/A |
| Operating Expenses | 81,075 | 70,330 | 58,594 | 65,155 | 51,168 |
| Operating Income | -80,994 | -65,052 | -58,594 | -28,191 | -51,168 |
| Other Income | 4,031 | 637 | 376 | 237 | 236 |
| Pre-tax Income | -76,963 | -64,415 | -58,218 | -27,954 | -50,932 |
| Income Tax | N/A | 528 | N/A | N/A | N/A |
| Net Income Continuous | -76,963 | -64,943 | -58,218 | -27,960 | -50,932 |
| Net Income | $-76,963 | $-64,943 | $-58,218 | $-27,960 | $-50,932 |
| EPS Basic Total Ops | -2.38 | -2.17 | -1.95 | -0.95 | -1.72 |
| EPS Basic Continuous Ops | -2.38 | -2.17 | -1.95 | -0.95 | -1.72 |
| EPS Diluted Total Ops | -2.38 | -2.17 | -1.95 | -0.95 | -1.72 |
| EPS Diluted Continuous Ops | -2.38 | -2.17 | -1.95 | -0.95 | -1.72 |
| EPS Diluted Before Non-Recurring Items | -2.38 | -2.17 | -1.95 | N/A | N/A |
| EBITDA(a) | $-81,494 | $-64,605 | $-58,061 | $-64,591 | $-50,750 |